Genetics of fulminant type 1 diabetes.
Kawabata Y, Ikegami H.
Diabetol Int. 2020 Sep 21;11(4):315-322. doi: 10.1007/s13340-020-00468-0. eCollection 2020 Oct.
Fulminant type 1 diabetes: recent research progress and future prospects.
Imagawa A, Tachibana M.
Diabetol Int. 2020 Sep 16;11(4):336-341. doi: 10.1007/s13340-020-00466-2. eCollection 2020 Oct.
Anti-Islet Autoantibodies in Type 1 Diabetes.
Kawasaki E.
Int J Mol Sci. 2023 Jun 11;24(12):10012. doi: 10.3390/ijms241210012.
Re-Enlightenment of Fulminant Type 1 Diabetes under the COVID-19 Pandemic.
Sano H, Imagawa A.
Biology (Basel). 2022 Nov 15;11(11):1662. doi: 10.3390/biology11111662.
Fulminant type 1 diabetes: A comprehensive review of an autoimmune condition.
Luo S, Ma X, Li X, Xie Z, Zhou Z.
Diabetes Metab Res Rev. 2020 Sep;36(6):e3317. doi: 10.1002/dmrr.3317. Epub 2020 Apr 6.
Fulminant type 1 diabetes: 20 years of discovery and development.
Hanafusa T.
Diabetol Int. 2020 Aug 24;11(4):310-314. doi: 10.1007/s13340-020-00458-2. eCollection 2020 Oct.
Fulminant type 1 diabetes: Focusing on triggering factors.
Qiu J, Yin W, Wang R, Luo S, Zhou Z.
Diabetes Metab Res Rev. 2024 Feb;40(2):e3731. doi: 10.1002/dmrr.3731. Epub 2023 Oct 10.
Fulminant Type 1 Diabetes-East and West.
Imagawa A, Hanafusa T.
J Clin Endocrinol Metab. 2023 Nov 17;108(12):e1473-e1478. doi: 10.1210/clinem/dgad329.
Recent findings on fulminant type 1 diabetes.
Liu L, Zeng L, Sang D, Lu Z, Shen J.
Diabetes Metab Res Rev. 2018 Jan;34(1). doi: 10.1002/dmrr.2928. Epub 2017 Sep 25.
Pathogenesis of fulminant type 1 diabetes: Genes, viruses and the immune mechanism, and usefulness of patient-derived induced pluripotent stem cells for future research.
Hosokawa Y, Hanafusa T, Imagawa A.
J Diabetes Investig. 2019 Sep;10(5):1158-1164. doi: 10.1111/jdi.13091. Epub 2019 Jul 8.
